Surprisingly, the neurological phenotype of GLRX5 mutation, comprising myelopathy and variable leukoencephalopathy, seizures, optic atrophy and peripheral neuropathy, is reminiscent of other multiple mitochondrial dysfunction syndromes caused by defects in late acting ISC proteins [6]. Here, GLRX5 is linked to optic atrophy.